How Nursing Home Providers Can Make Sense of CMS’ Value-Based Care ‘Alphabet Soup’
CMS is rolling out new value‑based care models that could reshape nursing home financing, with the Long‑Term Enhanced ACO Design (LEAD) and Transforming Episode Accountability Model (TEAM) highlighted as priority options. TEAM will soon place every lower‑extremity joint replacement under a bundled payment arrangement, while LEAD provides a ten‑year ACO framework tailored to long‑term care facilities. Recent CMS tweaks—such as lowering the MSSP alignment threshold to 800 high‑needs lives and permitting mid‑year voluntary alignment—make participation more attainable. Unmanaged Medicare fee‑for‑service spending in nursing homes totals about $18.9 billion, underscoring the potential savings from ACO integration.
‘Wild West’ of Hospice Fraud Intensifies in Texas
Texas has been identified as a hospice‑fraud hotbed, joining California, Arizona and Nevada in a surge of newly licensed operators that often engage in illegal billing. Regulators, citing cross‑state fraud, have imposed a six‑month CMS moratorium on new hospice and...
Representatives Join Hospital Leaders at AHA Briefing to Discuss Need for Legislation on Prompt Payment Standard for MA Plans
Hospital CEOs and members of Congress convened in Washington to push the Medicare Advantage Prompt Pay Act, H.R. 5454/S. 2879. The legislation would require Medicare Advantage plans to pay at least 95 % of clean claims within 14 days for in‑network services and...
Memorial Sloan Kettering Sues GE HealthCare over Imaging Tech
Memorial Sloan Kettering Cancer Center has filed a federal lawsuit against GE HealthCare, alleging that the company’s MotionFree technology embedded in PET/CT scanners infringes patents owned by the center’s physicist Adam Kesner. The patented method automatically corrects breathing‑induced motion in...
New York Attorney General Opens Probe Into Nassau University Medical Center
The New York attorney general’s office has opened an investigation into Nassau University Medical Center (NUMC) over alleged misuse of public funds for meals, travel and large exit payouts. The probe follows a June 2025 state law that transferred oversight...
STAT+: Alnylam to Partner with Inceptive Nucleics for AI Foundation Models for RNAi Therapeutics
Alnylam Pharmaceuticals has entered a three‑year strategic collaboration with Inceptive Nucleics, a startup founded by former Google Brain researcher Jakob Uszkoreit. The deal is valued at up to $2 billion, with $30 million paid upfront in cash and equity. Inceptive will apply...
Edwards Gets FDA Approval for Surgical Tricuspid Valve
Edwards Lifesciences received FDA clearance for Triformis Resilia, the first surgical valve specifically engineered for tricuspid valve disease. The device uses Edwards' Resilia tissue and a flattened sewing ring that mirrors the native annulus, offering a new surgical option in a...
New Data Support Pimicotinib as Durable for Rare Tenosynovial Giant Cell Tumor
Long‑term data presented at ASCO 2026 confirm that the oral CSF‑1R inhibitor pimicotinib delivers durable tumor shrinkage and functional gains in patients with tenosynovial giant cell tumor (TGCT). In the phase 3 MANEUVER trial, objective response rates hovered around 75‑80% across...
Acoramidis Shows Durable Benefit at 54 Months in ATTR-CM
Acoramidis (Attruby) demonstrated sustained reductions in all‑cause mortality, cardiovascular mortality, and first cardiovascular hospitalization through 54 months in an open‑label extension of the ATTRibute‑CM trial. The extension enrolled 389 patients, comparing continuous treatment with delayed initiation after placebo crossover. Continuous...
Compounding Information for States
The FDA’s compounding program deepens collaboration with state pharmacy boards by sharing data on non‑compliant compounders, complaints, adverse events, and inspection findings, and by inviting state participation in inspections. Under Section 105 of the Drug Quality and Security Act, states can...
White House Defends Loosened FDA Restrictions On E-Cigarettes
The White House and the Department of Health and Human Services defended a recent easing of FDA restrictions on electronic cigarettes, arguing the change will give adult smokers a safer alternative to combustible tobacco. The administration emphasized that the policy...
ASCO 2026 Spotlights Unmet Needs Across Cancer Care
At ASCO 2026, oncologists highlighted persistent gaps that hinder patient outcomes despite a surge of new therapies. Across prostate, brain and breast cancer, clinicians stressed that the sheer volume of treatment options exceeds current decision‑support tools and biomarker data. They...
Trump’s Medicaid Work Rules Force States To Scrap Plans and Rework Systems
CMS issued new regulations on June 1 tightening Medicaid work‑requirement exemptions, obligating states to assess the severity of medical conditions rather than merely confirming a diagnosis. The rule affects roughly 18.5 million adults in 42 states and the District of Columbia, and...
The BioPharm Brief: RNA Editing, Cardiac Remodeling, Rare Disease Gene Therapy
Eli Lilly has signed a licensing deal with Ascidian Therapeutics to use its RNA exon‑editing platform for inherited kidney diseases, underscoring the rise of reversible RNA‑based medicines. Tenaya Therapeutics presented interim results for its TN‑201 gene‑therapy, showing cardiac remodeling and lowered...
Bringing Digital Innovation From Lab to Life in Cardiology
BIOTRONIK, Charité – Universitätsmedizin Berlin, and the German Heart Center Foundation announced a research and innovation partnership to accelerate digital cardiology. The collaboration will combine BIOTRONIK’s AI, connected‑health, and implantable‑device expertise with Charité’s clinical cardiovascular program to develop AI‑driven tools...
Clinical and Economic Evaluation of Autonomous Artificial Intelligence in Musculoskeletal Therapeutics: Flok Health's Series A and the Shifting Competitive Landscape
Flok Health, a Cambridge‑based digital health firm, closed an oversubscribed $12.5 M Series A led by AlbionVC to scale its autonomous AI‑driven physiotherapy clinic across the NHS and into international markets. The platform, a CQC‑registered Class IIa medical device, can triage, diagnose, treat...
Food Noise Goes Quiet with GLP-1s
A new study examined how GLP‑1 weight‑loss drugs affect "food noise," the intrusive thoughts about food that can hinder healthy behavior. Researchers tracked 417 adults in WW International's digital program, with about a quarter receiving a GLP‑1 prescription. After one...
Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System
The Musculoskeletal Quality Collaborative (MSKQC), a surgeon‑led network across 14 hospitals, rolled out value‑based protocols in May 2023 to curb high‑cost consumables such as antibiotic‑infused bone cement, povidone‑iodine irrigation, and negative pressure wound therapy. Within a year, AIBC use fell from...
CMS Officially Launches $50 Price Tag for Weight Loss Drugs in Medicare
The Centers for Medicare & Medicaid Services announced a $50‑per‑month price cap for GLP‑1 weight‑loss drugs for eligible Medicare beneficiaries, effective July 1, 2024. The list price for these medications typically exceeds $1,000 a month, so the new cap represents a...
Life Sciences Patents Monthly Roundup—May 2026
In May 2026 European courts issued several landmark rulings affecting life‑science patents. The Brussels Enterprise Court affirmed the inventive step of EP 3297977 on radiopharmaceutical synthesis and clarified the scope of SPC manufacturing‑waiver notifications in the Regeneron‑Sandoz dispute. The Düsseldorf Local...
AI Triage Tool Slashes Breast Cancer Screening Workloads by 77%
A French study applied an AI‑enabled mammogram triage system to 55,589 screening exams from women aged 50‑74. The algorithm classified 76.6% of scans as low risk, allowing radiologists to skip a second read for those cases and potentially slash the...
As Peptides Go Mainstream, CeliaRx Aims To Cut Through The Noise
CeliaRx has introduced a physician‑guided telehealth platform that delivers personalized peptide therapy to consumers, aiming to move the once‑niche treatment into mainstream wellness. Founder Koehl Robinson, motivated by personal health challenges, emphasizes education, medical oversight, and evidence‑based protocols to cut...
Options, Pearls for Secondary IOL Implantation
Secondary intraocular lens (IOL) implantation remains a complex challenge for cataract surgeons, as no U.S.‑approved lenses are purpose‑designed for scleral fixation. Experts at Wills Eye Hospital and Baylor College of Medicine compare sutured Gore‑Tex fixation of the MX60 enVista with...
We Must Keep Pace as Alzheimer’s Treatment Enters a New Phase
Alzheimer’s research has entered a new era as the first disease‑modifying drugs demonstrate functional benefits for patients. The Alzheimer’s Association reports more than 150 therapies in roughly 200 trials, targeting at least 17 biological pathways beyond amyloid and tau. Real‑world...
Fifty Billion Dollars, and Patients Who Can’t Log In
The Rural Health Transformation Program (RHTP) is channeling roughly $50 billion to modernize rural health care through telehealth, remote monitoring, and data‑sharing infrastructure. However, a persistent digital‑literacy gap means many patients cannot log into portals or join video visits, undermining the...
Conscience Protection Laws: What Healthcare Employers Should Know
Effective May 6, 2026, Utah’s Senate Bill 174 enacted broad conscience‑protection provisions for healthcare workers, allowing them to refuse participation in procedures that conflict with sincerely held religious or moral beliefs. The law obligates employers to receive advance notice and to schedule staff...
FDA Hits Medline with Warning Letter over Long-Running Contamination Problem
Medline Industries, fresh from a $6.3 billion IPO, received two FDA warning letters in early 2026 for repeated bacterial contamination at separate facilities. Between June 2023 and August 2025, inspectors documented nine instances of objectionable microorganisms, including Bacillus cereus in five...
Is Productivity Improvement in Health Care Higher Than Commonly Assumed?
Two recent Bureau of Economic Analysis papers challenge the view that U.S. health‑care spending merely funds stagnant services. The first study estimates a 7.5% annual productivity gain for nine common Medicare conditions between 2002 and 2021, while a broader sector‑wide...
Individual Case Safety Reports
The HL7 Individual Case Safety Report (ICSR) standard, codified as ISO/HL7 27953, unifies pharmacovigilance messaging across ISO and HL7. Part 1 defines a flexible framework for exchanging adverse‑event data, while Part 2 maps the framework to ICH E2B(R3) and the IDMP product‑identification suite. The...
Top 8 Reasons Why Patients Are Choosing Specialty Infusion Care
Patients are increasingly opting for specialty infusion centers and home‑based care over traditional hospital outpatient departments. These venues deliver lower out‑of‑pocket costs, greater convenience, and a more private, comfortable environment. Providers such as Acelpa Health showcase benefits like specialized clinical...
Social Needs Screening and Supplemental Benefits in Medicare Advantage
In 2024 CMS authorized Medicare Advantage (MA) plans to screen for social determinants of health (SDOH) and to offer Special Supplemental Benefits for the Chronically Ill (SSBCI) that address those needs. A retrospective analysis of 2024 plan data shows that...
Sacituzumab Govitecan Combo Benefits Breast Cancer Subset
The phase 3 ASCENT‑04 trial showed that first‑line sacituzumab govitecan plus pembrolizumab improves progression‑free survival 2 (PFS2) by 33% versus chemotherapy plus pembrolizumab in PD‑L1‑positive metastatic triple‑negative breast cancer. The study enrolled 443 patients, permitted crossover to sacituzumab govitecan monotherapy, and reported...
FDA Rules, Regulations and Resources for Artificial Intelligence in Medical Devices
Medical device makers incorporating AI or machine learning must determine whether the software meets the FDA's definition of a medical device, which triggers regulatory oversight. The FDA classifies such products under the FD&C Act and requires marketing submissions like 510(k),...
Mexico’s Path Toward Universal Health Coverage
Mexico’s new Servicio Universal de Salud (SUS) decree, issued on April 7 2026, consolidates the IMSS, ISSSTE and IMSS‑Bienestar systems into a single universal health network covering roughly 120 million people. The framework grants citizens the right to receive care at any public...
Medtronic Boosts Revenue by Nearly Double Digits in Q4
Medtronic reported FY26 fourth‑quarter revenue of $9.8 billion, a near‑10% year‑over‑year increase, driving an 8.4% rise in full‑year revenue to $36.36 billion – its strongest top‑line growth in a decade. The surge was powered by the cardiovascular segment, especially cardiac ablation solutions,...
Other News to Note for June 3, 2026
At the 2026 ASCO Annual Meeting, Revolution Medicines expanded on its promising top‑line results, unveiling detailed efficacy data for a novel pancreatic cancer therapy that could reshape treatment standards. Meanwhile, the European Association for the Study of the Liver (EASL)...
Hem/Onc Fellows Lack Formal Training in AI Use
A multicenter survey of 118 U.S. hematology/oncology fellows presented at ASCO shows 74% are using AI tools such as ChatGPT, yet only 8% have received formal AI education. Fellows report high satisfaction with current didactics but express a strong desire...
Legend Surges on Early Data for ‘in Vivo’ Lymphoma Cell Therapy
Legend Biotech reported that its in‑vivo CAR‑T candidate LB2501 induced remission in all six patients receiving the higher dose in a first‑in‑human trial of relapsed lymphoma, with five complete responses. The therapy uses a viral vector to program immune cells...
Rethinking Long-Term Care and Disability Limitations
The article highlights a growing gap between the expectations placed on Medicaid‑funded long‑term care and disability services and the reality of limited caregiver capacity. An aging population and longer lifespans for people with disabilities are driving demand, while the workforce...
Outlook Therapeutics Resubmits BLA for ONS-5010
Outlook Therapeutics has resubmitted a biologics license application for ONS‑5010, an investigational bevacizumab ophthalmic formulation targeting neovascular age‑related macular degeneration. The FDA classified the filing as a Class 1 resubmission, meaning no additional clinical data are required and a PDUFA action...
NewLimit’s $435M Megaround; Lilly’s Busy Dealmaking Week
Longevity startup NewLimit announced a $435 million Series C round, the largest biotech raise this year, led by Founders Fund and joined by Eli Lilly Ventures among others. The capital will fund its epigenetic reprogramming platform, with a first liver‑reprogramming trial expected next...
NYU Langone Health to Build 500-Patient Bed Hospital in Melville on Long Island
NYU Langone Health announced plans to build a new 500‑bed hospital and academic medical center in Melville, Long Island. The $135.5 million, 45‑acre project will include more than 500 private inpatient rooms, 70 emergency department bays, advanced operating suites, and the...
Highlights of ASCO 2026: How Is Cancer Care Evolving?
At ASCO 2026, Revolution Medicine unveiled daraxonrasib, a KRAS‑off pill that halved death risk and doubled survival for metastatic pancreatic cancer in a phase‑3 trial of 500 patients. Johnson & Johnson’s Rybrevant Faspro earned Breakthrough Therapy designation, delivering a 42% response...
The American Diabetes Association’s Statement on the OMB’s Financial Assistance Proposed Rule
The White House Office of Management and Budget has proposed a rewrite of the Guidance for Federal Financial Assistance, implementing many provisions from President Trump’s 2025 executive order to tighten grant oversight. The rule would reshape reporting standards, performance metrics,...
Statement From the American Diabetes Association on the CMS’s Medicaid Work Requirements Interim Final Rule
The Centers for Medicare & Medicaid Services issued an interim final rule that will require most Medicaid beneficiaries to work, volunteer, or complete job training for at least 80 hours each month starting Jan. 1, 2027. The American Diabetes Association (ADA) warns...
Orlando Health Unveils Plans for New Hospital and ED in Viera
Orlando Health announced plans to build a new 240‑bed hospital on a 40‑acre campus in Viera, Florida, with groundbreaking slated for this month. The seven‑story facility will be paired with a 60,000‑square‑foot medical office building and will open its emergency...
CDER Drug Approvals that Used Real-World Evidence
Between 2021 and 2025, the FDA’s Center for Drug Evaluation and Research (CDER) approved a series of drugs and supplemental applications that incorporated real‑world evidence (RWE). The approvals spanned diverse therapeutic areas—from acetylcysteine dosing changes to new indications for rare...
AI-Enabled RCM Needs More than Just Good Tech
Omega Healthcare CEO Anurag Mehta says AI‑enabled revenue cycle management (RCM) must go beyond technology, emphasizing data quality, population health insights, and provider‑specific workflows. His firm partners with hospitals to customize AI tools that reflect each organization’s patient mix and...
Leveraging Integrated Workforce Data Is Integral to Transforming Healthcare Performance
Healthcare leaders are turning fragmented workforce data into a strategic asset by integrating it with clinical, financial and operational information. This integrated approach fuels a continuous workforce optimization cycle that enables proactive staffing, real‑time operational guidance and actionable insights. Leaders...
Ill. FD Raises Fees for Repeated Non-Emergency EMS Calls
The Schaumburg Fire Department announced a new fee schedule for repeated non‑emergency ambulance calls, charging $100 for the 11th call, $250 for the 12th, and $325 for each subsequent request within a year. The policy targets lift‑assist and household‑help calls...